United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the shortest

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximum

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 g - clotrimazole is a broad-spectrum antifungal agent that is used for the treatment of dermal infections caused by various species of pathogenic dermatophytes, yeasts, and malassezia furfur . the primary action of clotrimazole is against dividing and growing organisms. in vitro , clotrimazole exhibits fungistatic and fungicidal activity against isolates of trichophyton rubrum , trichophyton mentagrophytes , epidermophyton floccosum , microsporum canis and candida species including candida albicans . in general, the in vitro activity of clotrimazole corresponds to that of tolnaftate and griseofulvin against the mycelia of dermatophytes (trichophyton , microsporum , and epidermophyton ), and to that of the polyenes (amphotericin b and nystatin) against budding fungi (candida ). using an in vivo (mouse) and an in vitro (mouse kidney homogenate) testing system, clotrimazole and miconazole were equally effective in preventing the growth of the pseudomycelia and mycelia of candida albicans . strains

United States - English - NLM (National Library of Medicine)

padagis us llc - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg - clotrimazole lozenges are indicated for the local treatment of oropharyngeal candidiasis. the diagnoses should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole lozenges are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole lozenges are contraindicated in patients who are hypersensitive to any of its components. no data available.

United States - English - NLM (National Library of Medicine)

unit dose services - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximu

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 1% - clotrimazole 1% - azoles

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 2% - clotrimazole 2% - azoles

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 1% - clotrimazole 1% - azoles

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 1% - clotrimazole 1% - azoles

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 1% - clotrimazole 1% - azoles